L-leucine
Enable an AI agent to identify L-leucine, assess the identity and condition of a material containing it, and determine whether that material is suitable for a specified operation.
Research draft, second pass
A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.
Researched by: Codex
Purpose and description
Enable an AI agent to identify L-leucine, assess the identity and condition of a material containing it, and determine whether that material is suitable for a specified operation.
It can be Identify a candidate material using complementary connectivity and stereochemical evidence.; Quantify L-leucine while separating free, total-after-hydrolysis and stereochemically unresolved results.; Accept, quarantine or reject a batch against an explicit use-specific specification.; Calculate a weighed amount or dilution using the applicable assay and moisture basis.; Prepare and assess a solution or suspension under recorded conditions.; Link incorporation into a formulation, peptide or reaction product to the appropriate neighbouring model..
Distinguishing features
Require connectivity consistent with 2-amino-4-methylpentanoic acid and the L configuration, corresponding to the 2S stereocentre; an unqualified leucine label does not establish stereochemistry. [ChEBI L-leucine](https://www.ebi.ac.uk/chebi/CHEBI%3A15603)
Distinguish L-leucine from D-leucine and DL-leucine using evidence capable of resolving enantiomers; molecular formula or an achiral identity test alone is insufficient.
Distinguish leucine from isoleucine through side-chain connectivity: leucine has an isobutyl side chain, whereas isoleucine has a sec-butyl side chain; require a method demonstrated to distinguish them. [ChEBI L-isoleucine](https://www.ebi.ac.uk/chebi/CHEBI%3A17191)
Distinguish free L-leucine from a leucine residue released by protein or peptide hydrolysis by recording covalent context and sample preparation. [ChEBI L-leucine](https://www.ebi.ac.uk/chebi/CHEBI%3A15603)
Recognise the zwitterionic representation as related to L-leucine identity, while separately recording protonation and any counterions rather than treating every charged representation as a different ingredient. [ChEBI L-leucine zwitterion](https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A57427)
Scope
+ L-leucine molecular connectivity and stereochemical identity
+ Free L-leucine in powders, solutions and mixtures
+ L-leucine assay, enantiomeric composition and relevant impurities
+ Physical condition, dissolution behaviour and preparation history
+ Evidence supporting material acceptance for a specified use
- D-leucine and isoleucine as independently identified substances
- Peptide and protein sequence models containing leucine residues
- Complete models of leucine salts, protected derivatives and reaction products
- Finished supplement, food and pharmaceutical formulation models
- Patient nutrition, dosing, disease management and clinical benefit
- Organism-level leucine metabolism and signalling networks
Characteristics
- Connectivity and absolute configuration
- Structure identifier with explicit stereochemistry; confirmed L-leucine, conflicting identity or unresolved Prevents substitution by an enantiomer or a constitutional isomer.
- Chemical presentation
- Free amino acid, protonated or deprotonated species, salt-associated constituent, covalently bound residue or unresolved Determines whether this model directly describes the material or only a constituent relationship.
- L-leucine content
- Mass fraction %, mg/g, mol/L or mmol/L, with assay method, uncertainty and reporting basis Supports quantity calculations without confusing total leucine with specifically measured L-leucine.
- Enantiomeric composition
- L and D fractions of total leucine, or enantiomeric excess %, with method and detection limits Establishes stereochemical quality independently of bulk chemical purity.
- Related amino acid impurities
- Individual impurity concentrations in mg/g or %, with identity confidence and quantification limits Reveals contamination or analytical overlap that could inflate the reported leucine result.
- Water content
- % mass fraction with water-specific method, or separately identified loss-on-drying result Affects weighed potency and prevents treating all drying loss as water.
- Physical and dissolution state
- Powder, crystalline solid, solution or suspension; fully dissolved, residual solid, precipitated or unassessed Determines whether a transferred portion delivers the intended amount uniformly.
- Solution conditions
- pH, temperature in °C and solvent composition Provides the conditions needed to interpret protonation, solubility and preparation performance.
- Batch evidence
- Links to supplier lot, sampled portion, certificate, analytical results and preparation history Connects a claim about L-leucine to the material actually being evaluated.
- Use-specific disposition
- Unassessed, accepted for named use, quarantined, rejected or awaiting retest Prevents acceptance for one purpose from becoming unrestricted permission for another.
Where this came from
wikidata · CC0 1.0
Drafted structure
Bundle to layer to finding to question, as the second pass will find it: 5 bundles · 10 layers · 10 findings · 20 questions.
Leucine identity and boundaries Establish what qualifies as L-leucine and what must remain a related substance or constituent.
A leucine name or formula alone cannot resolve stereochemistry, isomerism or covalent context.
Connectivity and chirality
Assess independent evidence for the leucine skeleton and L configuration.
Confirmed L-leucine identity
Record the proposed identity, supporting observations and unresolved alternatives without upgrading a supplier label into analytical confirmation.
- What evidence establishes leucine connectivity and excludes isoleucine or other potentially confusable amino acids? definition
- What stereoselective evidence establishes the L configuration and constrains D-leucine content? measurement
Free, bound and ionic context
Separate protonation context from salts, covalent derivatives and leucine residues.
Chemical context assignment
Record whether the observation concerns free L-leucine, a related ionic species or leucine obtained from another material.
- Was L-leucine present freely in the original material, or was it released or chemically altered during preparation? boundary
- Which protonation conditions, counterions or covalent attachments require a relationship to a neighbouring substance model? boundary
Leucine assay and selectivity Determine how much L-leucine is present and whether the measurement actually resolves it.
A total amino acid result or unresolved leucine signal cannot automatically support an L-leucine quantity.
Measurand and reporting basis
Define the material fraction and chemical quantity represented by an assay.
Interpretable leucine quantity
Attach every amount to its sample, analytical target, units and moisture or preparation basis.
- Does the result measure free L-leucine, unresolved D-plus-L leucine or total leucine after hydrolysis? definition
- What amount is reported, with what uncertainty, and on an as-received, dry-mass or solution-volume basis? measurement
Interferences and reference materials
Assess whether the analytical method and calibration support the claimed specificity.
Assay specificity evidence
Record demonstrated separation or discrimination, calibration provenance and limitations relevant to leucine.
- Can this method distinguish leucine from isoleucine and distinguish its enantiomers, and which unresolved components remain? measurement
- Which reference material, calibration and sample-preparation records support the reported L-leucine result? provenance
Leucine batch composition Assess the actual batch beyond its nominal L-leucine identity.
Stereochemical purity, related amino acids and process-dependent contaminants can impose different acceptance limits.
Enantiomers and related amino acids
Separate L-leucine content from D-leucine and other amino acid components.
Resolved amino acid composition
Maintain distinct observations for chemical assay, enantiomeric composition and related amino acid impurities.
- What D-leucine fraction is measured or bounded, and what denominator defines the reported enantiomeric purity? measurement
- Which related amino acids are detected, and could any have been counted in the L-leucine assay? measurement
Production-linked quality
Connect manufacturing and handling evidence to the impurity assessment required for the intended use.
Batch quality evidence
Record the known production route and relevant water, residual-process-material and contamination results without inferring them from a grade label.
- What production route and lot-specific evidence establish which contaminants require assessment? provenance
- Which water, residual solvent, inorganic or microbiological limits apply to the intended use, and which results remain missing? boundary
Leucine physical preparation Describe the material state and conditions needed to obtain a usable L-leucine preparation.
Correct chemical identity does not establish that a powder transfers reproducibly or that a nominal solution is fully dissolved.
Solid condition and weighing
Assess powder condition and the basis for converting weighed material into L-leucine amount.
Weighable leucine material
Record physical changes and assay corrections relevant to obtaining a representative portion.
- Is the powder homogeneous and transferable, or do clumping, segregation or other observed changes require investigation? measurement
- What assay and moisture correction, if any, converts the proposed weighed mass into the required L-leucine amount? action
Dissolution and solution state
Record solvent conditions and evidence that the target preparation has been achieved.
Verified leucine preparation
Distinguish intended concentration from achieved dissolved concentration and track precipitation or residual solid.
- At the recorded solvent composition, pH and temperature, what evidence shows that the intended L-leucine amount has dissolved? measurement
- If solid remains or appears later, should the preparation be mixed as a suspension, adjusted under an approved procedure or rejected for its intended use? action
Leucine use and disposition Translate identity, composition and condition evidence into bounded material decisions.
L-leucine intended for an analytical reference, synthesis, culture medium or ingredient requires different evidence.
Use-specific acceptance
Tie material acceptance to a named operation and its governing specification.
Supported use decision
Record which proposed use is supported and which missing evidence prevents acceptance.
- What named operation and specification determine the required L-leucine identity, purity, concentration and contaminant limits? boundary
- Do the available results justify acceptance, quarantine, further testing or rejection for that operation? action
Condition history and transformations
Track events that could invalidate a prior assessment or move the material into another model.
Reassessment and model handoff
Relate storage and preparation history to reassessment, and link deliberate chemical transformation to the resulting substance.
- What storage excursions, container changes, preparation events or elapsed intervals trigger reassessment under the applicable stability evidence? action
- If L-leucine is derivatised, incorporated into a peptide or otherwise reacted, what resulting entity takes ownership of its new identity and state? boundary
What the second pass must settle
- Which existing Vercy publications already cover L-leucine or its chemical-state representations, and should this registry entry link to one of them?
- Which current specifications and acceptance limits apply to each intended grade and use of L-leucine?
- Which analytical methods demonstrate adequate leucine/isoleucine discrimination and D/L resolution in the matrices this model must support?
- What condition-specific solubility, solid-form and stability evidence supports preparation limits, storage requirements and retest intervals?
- Should isotopically enriched L-leucine remain a qualified instance of this entry or link to a separately registered tracer model?